Aytu Biopharma (AYTU) EBT Margin Growth (3y) (2017 - 2026)
Aytu Biopharma (AYTU) EBT Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 1,282.00 |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 58.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -861.00 |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -1,020.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | -995.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 1,157.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Aytu Biopharma | 24.70 Mn | -2.01 Mn | 7.60 Mn | -1,351.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,351.00 |
| Dec 31, 2025 | -4,432.00 |
| Sep 30, 2025 | 1,668.00 |
| Jun 30, 2025 | -6,985.00 |
| Mar 31, 2025 | 24,091.00 |
| Dec 31, 2024 | 5,231.00 |
| Sep 30, 2024 | 13,672.00 |
| Jun 30, 2024 | 6,242.00 |
| Dec 31, 2023 | 7,035.00 |
| Sep 30, 2023 | -1,009.00 |
| Jun 30, 2023 | 4,101.00 |
| Mar 31, 2023 | 3,371.00 |
| Dec 31, 2022 | 14,505.00 |
| Sep 30, 2022 | 33,993.00 |
| Jun 30, 2022 | 20,832.00 |
| Mar 31, 2022 | -3,125.00 |
| Dec 31, 2021 | 21,068.00 |
| Sep 30, 2021 | 11,634.00 |
| Jun 30, 2021 | 41,484.00 |
| Dec 31, 2020 | 33,580.00 |